SavedAdd your journal

Journals / Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2014 / Cilt: 47 - Sayı: 3

TREATMENT OF SEPSIS AND SEPTIK SHOCK

SEPSİS VE SEPTİK ŞOK TEDAVİSİ

Ömer Faruk KÖKOĞLU
Selma ATEŞ GÜLER
Pages
130–137
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Delay in diagnosis and initiation of treatment have been shown to increase mortality.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Severe sepsis and septic shock is a leading cause of morbidity and mortality.
📊
Key Findings & Data:The management of a patient with severe sepsis is important to haemodynamic treatment is to restore perfusion by fluid resuscitation, vazopresör, and inotrope therapy.
💡
Conclusion & Impact:Delay in diagnosis and initiation of treatment have been shown to increase mortality.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Severe sepsis and septic shock is a leading cause of morbidity and mortality. The management of a patient with severe sepsis is important to haemodynamic treatment is to restore perfusion by fluid resuscitation, vazopresör, and inotrope therapy. Diagnose the infection, to collect samples immediately after diagnosis and to initiate promptly broad-spectrum antibiotic treatment. The choice of empirical antimicrobial therapy should be based on host characteristics, site of infection and local antibiotic resistance. Delay in diagnosis and initiation of treatment have been shown to increase mortality.

Özet

Ciddi sepsis ve septik şok morbidite, mortaliteye neden olmaktadır. Sepsisin erken dönemde tanınıp perfüzyonun sağlanması için sıvı replasmanı, vazopressör ve inotrop gibi ek destek tedavilerin başlanması önemlidir. Daha sonra enfeksiyonu teşhis etmek için uygun kültür alınmalı ve erken dönemde uygun geniş spektrumlu antimikrobiyal tedavi başlanmalıdır. Ampirik antibiyotik tedavi seçiminde konak özellikleri, enfeksiyonun yeri, lokal antibiyotik direnci göz önünde bulundurulmalıdır. Teşhis ve tedavide gecikme mortalite artışına sebep olur.

🔖

Cite This Article

KÖKOĞLU, Ö. F., GÜLER, S. A. (2022). TREATMENT OF SEPSIS AND SEPTIK SHOCK. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 47 - Sayı: 3, 130–137. https://ajindex.com/articles/441428

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Nathan Coxford R, Lang E, Dowling SDopamine versus norepinephrine in the treatment of shock. CJEM. 2011
  2. Wilkman K,Kaukonen K M, PettiläV, KuitunenA, Varpula A. Association between inotrope treatment and 90-day mortality in patients with septic shock. Acta Anaesthesiol Scand. 2013
  3. Bateman BT, Schmidt U, Berman MF, Bittner EA. Temporal trends in the epidemiology of severe postoperative sepsis after elective surgery: a large, nationwide sample. Anesthesiology. 2010
  4. 917–925. 4)Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients with Severe Sepsis. http://www.clinicaltrials. gov/ct2/show/NCT00334828 (Accessed on June 12, 2011). 5)Rice TW, Wheel er AP, Bernard GR, et al. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med. 2010
  5. 6 6)Safety and Efficacy of Recombinant Human Lactoferrin to Treat Severe Sepsis. http://www.clinicaltrials.gov/ ct2/show/NCT00630656 (Accessed on June 12, 2011). 7)Guntupalli K, Dean N, Morris PE, Bandi V, Margolis B, Rivers E, Levy M, Lodato RF, Ismail PM, Reese A, Schaumberg JP, Malik R, Dellinger RP
  6. TLF LF-0801 Investigator Group. Talactoferrin alfa reduces mortality in severe sepsis: Results of a Phase 2 randomized, placebo-controlled, double-blind study. Crit Care Med. 2013
  7. Rangel-Frausto MS, Pittet D, Costigan M, et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 1995 11
  8. 23 9)Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet. 2005
  9. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2000. Crit Care Med. 2008
  10. Sessler CN, Perry JC, Varney KL. Management of severe sepsis and septic shock. Curr Opin Crit Care. 2004
  11. Hollenberg SM, Ahrens TS, Annane D, et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med. 2004
  12. Moore LJ, Moore FA. Early diagnosis and evidence- based care of surgical sepsis. J Intensive Care Med. 2013
  13. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001
  14. 17 15)Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med